Actively Recruiting
Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery
Led by Qianfoshan Hospital · Updated on 2024-09-26
207
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To examine the impact of various administration routes of dexmedetomidine in conjunction with ultrasound-guided fascia iliaca block (FIB) on emergence agitation (EA) during the postoperative recovery period after hip replacement surgery.
CONDITIONS
Official Title
Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Diagnosis of hip joint disease requiring hip arthroplasty
- American Society of Anesthesiologists (ASA) grade I or II
- No significant heart, lung, liver, or kidney problems before surgery
- No history of psychiatric disorders or long-term sedative use before surgery
- Signed informed consent to participate voluntarily
You will not qualify if you...
- Allergy or contraindication to ropivacaine or dexmedetomidine
- Agitation or delirium symptoms before the procedure
- Severe central or peripheral nervous system disorders
- Blood clotting problems or receiving blood-thinning treatment
- Pregnant or breastfeeding women
- Use of other medications or treatments before the procedure that could affect results
- Inability to cooperate with the study or intolerance to ultrasound-guided fascia iliaca block
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qianfoshan Hospital
Jinan, Shandong, China, 250000
Actively Recruiting
Research Team
P
Pengcai Shi, Chief physician
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here